Cargando…

Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges

Parasite resistance against anti-malarial drugs is a major threat to the ongoing malaria control and elimination strategies. This is especially true since resistance to the currently recommended artemisinins and partner drugs has been confirmed in South East Asia (SEA) and new anti-malarial compound...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishengoma, Deus S., Saidi, Queen, Sibley, Carol H., Roper, Cally, Alifrangis, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719357/ https://www.ncbi.nlm.nih.gov/pubmed/31477109 http://dx.doi.org/10.1186/s12936-019-2853-4

Ejemplares similares

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa
por: Tessema, Sofonias K., et al.
Publicado: (2019)

Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa
por: Nsanzabana, Christian
Publicado: (2021)

Independent Origin of Plasmodium falciparum Antifolate Super-Resistance, Uganda, Tanzania, and Ethiopia
por: Alifrangis, Michael, et al.
Publicado: (2014)

Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
por: Gaillard, Tiphaine, et al.
Publicado: (2018)

Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976–78
por: Jovel, Irina T., et al.
Publicado: (2017)

The contribution of non-malarial febrile illness co-infections to Plasmodium falciparum case counts in health facilities in sub-Saharan Africa
por: Dalrymple, Ursula, et al.
Publicado: (2019)

Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal
por: Ranjitkar, Samir, et al.
Publicado: (2011)

Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania
por: Kavishe, Reginald A, et al.
Publicado: (2014)

The prevalence of Plasmodium falciparum in sub Saharan Africa since 1900
por: Snow, Robert W, et al.
Publicado: (2017)

Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum
por: Flegg, Jennifer A, et al.
Publicado: (2013)

Plasmodium falciparum in Asymptomatic Immigrants from Sub-Saharan Africa, Spain
por: Monge-Maillo, Begoña, et al.
Publicado: (2012)

Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania
por: Shayo, Alex, et al.
Publicado: (2015)

THE CULTIVATION OF MALARIAL PLASMODIA (PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM) IN VITRO
por: Bass, C. C., et al.
Publicado: (1912)

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa
por: Okell, Lucy C., et al.
Publicado: (2017)

Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation
por: Fonte, Luis, et al.
Publicado: (2021)

Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2011)

How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?
por: Sutherland, Colin J, et al.
Publicado: (2007)

Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa
por: Griffin, Jamie T., et al.
Publicado: (2014)

Challenges in disclosure of adverse events and errors in surgery; perspectives from sub-Saharan Africa
por: Ibrahim, Abdulrasheed, et al.
Publicado: (2012)

Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum
por: Smith-Aguasca, Rebecca, et al.
Publicado: (2019)

Systems Analysis of Chaperone Networks in the Malarial Parasite Plasmodium falciparum
por: Pavithra, Soundara Raghavan, et al.
Publicado: (2007)

The Next Opportunity in Anti-Malaria Drug Discovery: The Liver Stage
por: Derbyshire, Emily R., et al.
Publicado: (2011)

Maintaining routine HIV and tuberculosis testing services in sub-Saharan African countries in the context of COVID-19: Lessons learnt and opportunities for improvement
por: Odhiambo, Collins O., et al.
Publicado: (2021)

Harmful Use of Alcohol: A Shadow over Sub-Saharan Africa in Need of Workable Solutions
por: Ferreira-Borges, Carina, et al.
Publicado: (2017)

Evidence for differences in erythrocyte surface receptors for the malarial parasites, Plasmodium falciparum and Plasmodium knowlesi
Publicado: (1977)

Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa
por: Watson, Oliver J, et al.
Publicado: (2017)

Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity
por: Perlaza, Blanca-Liliana, et al.
Publicado: (2011)

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania
por: Baraka, Vito, et al.
Publicado: (2015)

Spatial variation and socio-economic determinants of Plasmodium falciparum infection in northeastern Tanzania
por: Mmbando, Bruno P, et al.
Publicado: (2011)

A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria
por: Adegbola, Adebanjo J., et al.
Publicado: (2023)

Plasmodium malariae structure and genetic diversity in sub-Saharan Africa determined from microsatellite variants and linked SNPs in orthologues of antimalarial resistance genes
por: Oriero, Eniyou C., et al.
Publicado: (2022)

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
por: Peatey, Christopher L, et al.
Publicado: (2012)

Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa
por: Fonte, Luis, et al.
Publicado: (2022)

Is there evidence of anti-malarial multidrug resistance in Burkina Faso?
por: Rasmussen, Charlotte, et al.
Publicado: (2021)

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
por: Monatrakul, Preeyaporn, et al.
Publicado: (2010)

Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa
por: Mwingira, Felista, et al.
Publicado: (2011)

Diversion at the ER: How Plasmodium falciparum exports proteins into host erythrocytes
por: Römisch, Karin
Publicado: (2012)

Achieving development goals for HIV, tuberculosis and malaria in sub-Saharan Africa through integrated antenatal care: barriers and challenges
por: Fowkes, Freya J. I., et al.
Publicado: (2016)

Crystal structure of the aquaglyceroporin PfAQP from the malarial parasite Plasmodium falciparum
por: Newby, Zachary E R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_q4oqgrhlpb2rr7hca10cbbqi3s